Targeting the Keap1-Nrf2 Axis in COPD: Comparative analysis of electrophilic and peptide-based Nrf2 activators in airway and immune cells
| dc.contributor.author | Roger Laparra, Inés | |
| dc.contributor.author | Estornut Navarro, Cristina | |
| dc.contributor.author | Montero, Paula | |
| dc.contributor.author | Aparici, Mónica | |
| dc.contributor.author | Puig, Carlos | |
| dc.contributor.author | Davis, Andre M. | |
| dc.contributor.author | Albericio, Fernando | |
| dc.contributor.author | Diego, Alfredo de | |
| dc.contributor.author | Milara, Javier | |
| dc.contributor.author | Cortijo, Julio | |
| dc.date.accessioned | 2026-04-09T07:52:07Z | |
| dc.date.available | 2026-04-09T07:52:07Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | Chronic obstructive pulmonary disease (COPD) is characterized by sustained oxidative stress, inflammation, and epithelial damage. The transcription factor Nrf2 is a master regulator of antioxidant and cytoprotective defenses, and its dysregulation has been implicated in COPD pathogenesis. | en |
| dc.description.filiation | UEV | |
| dc.description.impact | 4.7 Q1 JCR 2024 | |
| dc.description.impact | 1.197 Q1 SJR 2024 | |
| dc.description.impact | No data IDR 2024 | |
| dc.description.sponsorship | PID2020-114871RB-I00 | |
| dc.description.sponsorship | CIBERES (CB06/06/0027) | |
| dc.description.sponsorship | Instituto de Salud Carlos III, PI20/01363 | |
| dc.description.sponsorship | Prometeo 2017/023/UV | |
| dc.description.sponsorship | CIGE/2023/171 | |
| dc.identifier.citation | Roger, I., Estornut, C., Montero, P., Aparici, M., Puig, C., Davis, A. M., Albericio, F., De Diego, A., Milara, J., & Cortijo, J. (2026). Targeting the Keap1-Nrf2 Axis in COPD: Comparative analysis of electrophilic and peptide-based Nrf2 activators in airway and immune cells. European Journal of Pharmacology, 1019, 178716. https://doi.org/10.1016/j.ejphar.2026.178716 | |
| dc.identifier.doi | 10.1016/j.ejphar.2026.178716 | |
| dc.identifier.issn | 0014-2999 | |
| dc.identifier.issn | 1879-0712 | |
| dc.identifier.uri | https://hdl.handle.net/11268/17015 | |
| dc.language.iso | eng | |
| dc.peerreviewed | Si | |
| dc.relation.publisherversion | https://doi.org/10.1016/j.ejphar.2026.178716 | |
| dc.rights.accessRights | embargoed access | |
| dc.subject.other | Biociencias | |
| dc.subject.other | Enfermedad Pulmonar Obstructiva Crónica | |
| dc.subject.other | Activación Neutrófila | |
| dc.subject.other | Sistema Inmunológico | |
| dc.subject.sdg | Goal 3: Ensure healthy lives and promote well-being for all at all ages | |
| dc.subject.unesco | Inmunología | |
| dc.subject.unesco | Aparato respiratorio | |
| dc.subject.unesco | Investigación médica | |
| dc.title | Targeting the Keap1-Nrf2 Axis in COPD: Comparative analysis of electrophilic and peptide-based Nrf2 activators in airway and immune cells | en |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1

